You have 9 free searches left this month | for more free features.

Optic Atrophy

Showing 1 - 25 of 2,275

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation

Not yet recruiting
  • Autosomal Dominant Optic Atrophy
  • +3 more
    • Sydney, Australia
      Sydney Eye Hospital
    Nov 15, 2023

    Nicotinamide Adverse Reaction Trial (Nicotinamide)

    Not yet recruiting
    • Nicotinamide Adverse Reaction
    • (no location specified)
    Aug 29, 2023

    Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)

    Recruiting
    • Retinal Disease
    • +17 more
    • Arm 1
    • Westport, Connecticut
    • +2 more
    Nov 25, 2022

    Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)

    Not yet recruiting
    • Leber Hereditary Optic Neuropathy (LHON)
    • NFS-02 Injection
    • (no location specified)
    Apr 6, 2023

    Neurodegenerative Disease, Hereditary, Mitochondrial Diseases, Optic Atrophy Trial in Buffalo (Mutation analysis)

    Recruiting
    • Neurodegenerative Disease, Hereditary
    • +2 more
    • Mutation analysis
    • Buffalo, New York
      UBMD Pediatrics
    Mar 3, 2022

    Neurodegenerative Disease, Hereditary, Mitochondrial Diseases, Optic Atrophy Trial in Buffalo (Mutation analysis)

    Recruiting
    • Neurodegenerative Disease, Hereditary
    • +2 more
    • Mutation analysis
    • Buffalo, New York
      UBMD Pediatrics
    Mar 3, 2022

    Trial

    Not yet recruiting
    • Leber Hereditary Optic Neuropathy (LHON)
    • NR082 Injection
    • Injection needle
    • (no location specified)
    Jan 30, 2023

    Disease and Visual Disability on Quality of Life and Loss of

    Recruiting
    • Leber's Hereditary Optic Neuropathy (LHON)
      • Orléans, France
        Argo Sante
      Sep 22, 2022

      Optic Atrophy Trial in Alexandria (Systemic erythropoietin injection)

      Completed
      • Optic Atrophy
      • Systemic erythropoietin injection
      • Alexandria, Egypt
        Alexandria Faculty of Medicine
      Jul 11, 2021

      Eye Diseases, Retinitis Pigmentosa, Glaucoma Trial in St. John's (AlloRx)

      Recruiting
      • Eye Diseases
      • +6 more
      • AlloRx
      • St. John's, Antigua and Barbuda
        Medical Surgical Associates Center
      Jan 4, 2022

      Ischemic Optic Neuropathy, Branch Retinal Artery Occlusion, Hemianopia Trial in Iowa City (LSFG-NAVI)

      Recruiting
      • Ischemic Optic Neuropathy
      • +4 more
      • LSFG-NAVI
      • Iowa City, Iowa
        University of Iowa Department of Ophthalmology
      Jul 4, 2022

      Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber) Trial (GS010)

      Available
      • Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber)
      • GS010
      • (no location specified)
      Aug 2, 2021

      Wolfram Syndrome, Diabetes, Optic Nerve Atrophy Trial in Saint Louis (dantrolene sodium)

      Active, not recruiting
      • Wolfram Syndrome
      • +3 more
      • dantrolene sodium
      • Saint Louis, Missouri
        Washington University School of Medicine
      Feb 16, 2022

      Leber's Hereditary Optic Neuropathy (LHON) Trial in Beijing (NR082 injection, Sham Injection)

      Recruiting
      • Leber's Hereditary Optic Neuropathy (LHON)
      • NR082 injection
      • Sham Injection
      • Beijing, China
        Beijing Tongren Hospital, Capital Medical University
      Dec 21, 2021

      Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay Trial in Saguenay (Rehabilitation)

      Recruiting
      • Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
      • Rehabilitation
      • Saguenay, Quebec, Canada
        Groupe de recherche interdisciplinaire sur les maladies neuromus
      Mar 3, 2023

      Leber Hereditary Optic Neuropathy Trial in Worldwide (GS010, Sham)

      Completed
      • Leber Hereditary Optic Neuropathy
      • GS010
      • Sham
      • Pasadena, California
      • +6 more
      Jul 25, 2022

      Leber's Hereditary Optic Neuropathy Trial in Pasadena (elamipretide (MTP-131) 1% topical ophthalmic solution, Vehicle topical

      Completed
      • Leber's Hereditary Optic Neuropathy
      • elamipretide (MTP-131) 1% topical ophthalmic solution
      • Vehicle topical ophthalmic solution
      • Pasadena, California
        Doheny Eye Center
      Nov 29, 2021

      Multiple Eye Fundus Diseases From Color Fundus Photograph

      Completed
      • Diabetic Retinopathy
      • +12 more
      • Software assisted imaging diagnosis
      • BeiJing, Beijing, China
      • +4 more
      Dec 28, 2021

      Leber Hereditary Optic Neuropathy Trial in Worldwide (GS010, Placebo)

      Active, not recruiting
      • Leber Hereditary Optic Neuropathy
      • GS010
      • Placebo
      • Pasadena, California
      • +12 more
      Aug 2, 2022

      Retinitis Pigmentosa, Leber's Hereditary Optic Neuropathy, Stargardt Disease Trial in Paris (Dynamic pupillometry sessions)

      Completed
      • Retinitis Pigmentosa
      • +2 more
      • Dynamic pupillometry sessions
      • Paris, France
        Centre Hospitalier National D'Ophtalùmologie des Quinze-Vingts
      May 28, 2021

      Safety Issues, Efficacy, Self Trial in Paris (Béfizal)

      Recruiting
      • Safety Issues
      • Efficacy, Self
      • Paris, France
        HEGP Hospital
      Feb 9, 2021

      Leber's Hereditary Optic Neuropathy Trial in Miami (injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),, injection of scAAV2-P1ND4v2

      Active, not recruiting
      • Leber's Hereditary Optic Neuropathy
      • injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),
      • +3 more
      • Miami, Florida
        Bascom Palmer Eye Institute, University of Miami
      Jul 1, 2021

      Leber Hereditary Optic Neuropathy Trial in Worldwide (Patient-reported outcomes (PROs))

      Completed
      • Leber Hereditary Optic Neuropathy
      • Patient-reported outcomes (PROs)
      • Pasadena, California
      • +10 more
      Feb 3, 2021

      Leber Hereditary Optic Neuropathy Trial in Wuhan (rAAV2-ND4)

      Active, not recruiting
      • Leber Hereditary Optic Neuropathy
      • Wuhan, Hubei, China
        Department of Ophthalmology,Tongji Hospital, Tongji Medical Coll
      Sep 15, 2020

      Post Authorisation Safety Study With Raxone in LHON Patients

      Completed
      • Leber's Hereditary Optic Neuropathy (LHON)
      • Graz, Austria
      • +25 more
      Jul 15, 2021